[go: up one dir, main page]

MX9602973A - Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida. - Google Patents

Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.

Info

Publication number
MX9602973A
MX9602973A MX9602973A MX9602973A MX9602973A MX 9602973 A MX9602973 A MX 9602973A MX 9602973 A MX9602973 A MX 9602973A MX 9602973 A MX9602973 A MX 9602973A MX 9602973 A MX9602973 A MX 9602973A
Authority
MX
Mexico
Prior art keywords
bradyquinine
antagonist
cosmetic
pharmaceutical
composition
Prior art date
Application number
MX9602973A
Other languages
English (en)
Inventor
Lionel Breton
Oliviere De Lacharriere
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of MX9602973A publication Critical patent/MX9602973A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere al uso de un antagonista de bradiquinina en una composicion cosmética, farmacéutica o dermatologica para tratar la piel sensible. La invencion se refiere en particular al uso de un antagonista de bradiquinina para prevenir y/o combatir las irritaciones de la piel y/o enfermedades inflamatorias de la piel y/o eritema y/o sensaciones disaestésicas y/o sensaciones de calentamiento y/o prurito de la piel y/o de las membranas mucosas. La invencion también se refiere a una composicion que contiene un antagonista de bradiquinina que limita o elimina los efectos secundarios irritantes de ciertos productos y, en particular, de ciertos agentes activos, cosméticos, dermatologicos o farmacéuticos.
MX9602973A 1995-07-31 1996-07-24 Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida. MX9602973A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509304A FR2737408B1 (fr) 1995-07-31 1995-07-31 Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue

Publications (1)

Publication Number Publication Date
MX9602973A true MX9602973A (es) 1997-01-31

Family

ID=9481558

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602973A MX9602973A (es) 1995-07-31 1996-07-24 Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.

Country Status (11)

Country Link
US (3) US5849312A (es)
EP (1) EP0756862B1 (es)
JP (1) JP2922157B2 (es)
AR (1) AR002908A1 (es)
AT (1) ATE164998T1 (es)
BR (1) BR9604031A (es)
CA (1) CA2182030C (es)
DE (1) DE69600239T2 (es)
ES (1) ES2118009T3 (es)
FR (1) FR2737408B1 (es)
MX (1) MX9602973A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6488940B2 (en) 1997-08-21 2002-12-03 Johnson & Johnson Consumer Companies, Inc. Use of 17-α-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6699486B1 (en) * 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
AU1618901A (en) * 1999-11-18 2001-05-30 John D. Bolla Treatment of rosacea
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
US6632420B1 (en) 2000-09-28 2003-10-14 The Gillette Company Personal care product
US7169400B2 (en) 2002-05-07 2007-01-30 Fort James Corporation Waterless lotion and lotion-treated substrate
US8012495B2 (en) * 2002-05-07 2011-09-06 Georgia-Pacific Consumer Products Lp Lotion-treated tissue and towel
US8100830B2 (en) * 2002-06-25 2012-01-24 Societe L'oreal S.A. Non-therapeutic methods of evaluating skin neurosensitivity, kit and use of a kit for implementing the method
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
DE10254872A1 (de) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
US7211566B2 (en) * 2003-04-01 2007-05-01 Universite De Sherbrooke Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof
FR2870139B1 (fr) * 2004-05-14 2006-07-07 Luc Doublet Moyens pour la coloration de supports
CA2635784C (en) * 2005-12-30 2012-06-12 Revance Therapeutics, Inc. Arginine heteromers for topical administration
FR2916966B1 (fr) * 2007-06-11 2011-01-14 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
AT507051B1 (de) * 2008-06-27 2015-05-15 Chemiefaser Lenzing Ag Cellulosefaser und verfahren zu ihrer herstellung
JP4406035B1 (ja) * 2008-07-09 2010-01-27 株式会社資生堂 水中油型乳化皮膚化粧料
US20120046362A1 (en) * 2009-04-17 2012-02-23 Hiroshima University Antiviral agent and cleansing agent
FR3117776B1 (fr) * 2020-12-18 2024-03-08 Oreal Extrait de bactérie du genreSphingomonas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58501675A (ja) * 1981-10-09 1983-10-06 フエ−リング・ア−ベ− 物質ｐ「きつ」抗質からなる薬材
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9201179D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9222486D0 (en) * 1992-10-26 1992-12-09 Merck Sharp & Dohme Therapeutic agents
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue

Also Published As

Publication number Publication date
FR2737408B1 (fr) 1997-09-05
BR9604031A (pt) 1998-04-22
DE69600239T2 (de) 1998-08-06
US5849312A (en) 1998-12-15
CA2182030A1 (fr) 1997-02-01
FR2737408A1 (fr) 1997-02-07
EP0756862B1 (fr) 1998-04-15
AR002908A1 (es) 1998-04-29
ES2118009T3 (es) 1998-09-01
ATE164998T1 (de) 1998-05-15
JP2922157B2 (ja) 1999-07-19
US6241993B1 (en) 2001-06-05
US20010028889A1 (en) 2001-10-11
CA2182030C (fr) 2002-02-19
JPH09104607A (ja) 1997-04-22
DE69600239D1 (de) 1998-05-20
EP0756862A1 (fr) 1997-02-05

Similar Documents

Publication Publication Date Title
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
FR2728793B1 (es)
HUT74037A (en) Thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
HU9503861D0 (en) Thermoplastic elastomeric copolymers and hair and skin care compositions containing the same
DE69421188D1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
MA23311A1 (fr) Copolymeres elastomeres thermoplastiques greffes a une silmicone et composition de soin des cheveux et de la peau les contenant .
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
ATE526944T1 (de) Selbstbräunungszusammensetzungen die cholesterolsulfat und dha enthalten
TR200100637T2 (tr) Yeni doğal ürün türevleri
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
TNSN96016A1 (fr) Utilisation de phenylcyclohexylcarboxamides
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche